Advances in the Treatment of Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Advances in the Treatment of Non-Small Cell Lung Cancer

Published:2014-05 Issue:5S Volume:12 Page:764-767
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:J Natl Compr Canc Netw

Author:

Horn Leora¹

Affiliation:

1. Presented by Leora Horn, MD, MSc, Associate Professor of Medicine, Department of Hematology Oncology; Clinical Director, Thoracic Oncology Research Program, Vanderbilt University, Nashville, Tennessee.

Abstract

Clinical trial data continue to emerge on treatments in advanced non-small cell lung cancer (NSCLC), supporting the strategy that histology and molecular driver mutations should guide treatment selection. During her presentation at the NCCN 19th Annual Conference, Dr. Leora Horn highlighted 3 specific areas in which the 2014 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for NSCLC focus attention: updates on the assortment of chemotherapy options, targeted therapies and how acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors appears to have become the catalyst of the development of newer-generations of agents, and the revisited role of newer immunotherapeutic options.

Publisher

Harborside Press, LLC

Subject

Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma;Medical Science Monitor;2022-07-25

2. Real-World Utilization of Target- and Immunotherapies for Lung Cancer: A Scoping Review of Studies Based on Routinely Collected Electronic Healthcare Data;International Journal of Environmental Research and Public Health;2021-07-19

3. Biological therapies in lung cancer treatment: using our immune system as an ally to defeat the malignancy;Expert Opinion on Biological Therapy;2019-02-27

4. CD147-mediated glucose metabolic regulation contributes to the predictive role of18F-FDG PET/CT imaging for EGFR-TKI treatment sensitivity in NSCLC;Molecular Carcinogenesis;2018-10-25

5. Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice;Cell Death & Disease;2018-02